Thomas Pulliam

Post-doctoral Fellow at The University of Texas MD Anderson Cancer Center with PhD in Cell and Molecular Biology

Houston, Texas, United States of America

Research Expertise

Cancer
Molecular Biology
Cell Signaling
Angiogenesis
Metabolism
Lipids
Prostate Cancer
Endocrinology
Metabolic Syndrome
Cancer Diet Studies

About

Thomas Pulliam is a highly educated and experienced scientist, with a strong background in cancer, cell, and molecular biology. He received his PhD in Cell and Molecular Biology from the University of Houston in 2021, after completing his BSc in Biology at Lamar University in 2014. He is currently a post-doctoral fellow in the department of Cancer Systems Imaging at The University of Texas MD Anderson Cancer Center. Throughout his education, Thomas has gained valuable research experience through various positions as a graduate research assistant and teaching assistant at the University of Houston. He has also worked as a Beach Water Sample Analyzer for the Texas General Land Office, where he honed his analytical skills. In addition to his academic achievements, Thomas has also served in the United States Marine Corps as a Chemical, Biological, Nuclear, and Radiological Defense Specialist. This experience has given him a strong sense of discipline, teamwork, and problem-solving skills. With his diverse background and expertise in cancer and molecular biology, Thomas is committed to making significant contributions to the field of cancer research. He is a driven and dedicated scientist, always seeking new challenges and opportunities to further his knowledge and skills.

Publications

Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity

Cancer Research / Dec 01, 2023

Awad, D., Cao, P. H. A., Pulliam, T. L., Spradlin, M., Subramani, E., Tellman, T. V., Ribeiro, C. F., Muzzioli, R., Jewell, B. E., Pakula, H., Ackroyd, J. J., Murray, M. M., Han, J. J., Leng, M., Jain, A., Piyarathna, B., Liu, J., Song, X., Zhang, J., … Frigo, D. E. (2023). Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity. Cancer Research, 84(5), 703–724. https://doi.org/10.1158/0008-5472.can-23-0555

Adipose triglyceride lipase is regulated by CAMKK2-AMPK signaling and drives advanced prostate cancer

Nov 03, 2022

Awad, D., Pulliam, T. L., Spradlin, M., Cao, P. H.-A., Subramani, E., Tellman, T. V., Ribeiro, C. F., Pakula, H., Ackroyd, J. J., Murray, M. M., Han, J. J., Piyarathna, B., Drake, J. M., Ittmann, M. M., Coarfa, C., Farach-Carson, M. C., Loda, M., Eberlin, L. S., & Frigo, D. E. (2022). Adipose triglyceride lipase is regulated by CAMKK2-AMPK signaling and drives advanced prostate cancer. https://doi.org/10.1101/2022.11.02.514910

SGC-CAMKK2-1: A chemical probe for CAMKK2

Oct 20, 2022

Wells, C., Liang, Y., Pulliam, T. L., Lin, C., Awad, D., Eduful, B., O’Byrne, S., Hossain, M. A., Catta-Preta, C. M. C., Ramos, P. Z., Gileadi, O., Gileadi, C., Couñago, R. M., Stork, B., Langendorf, C. G., Nay, K., Oakhill, J., Mukherjee, D., Racioppi, L., … Drewry, D. H. (2022). SGC-CAMKK2-1: A chemical probe for CAMKK2. https://doi.org/10.1101/2022.10.18.512752

Systemic Ablation of Camkk2 Impairs Metastatic Colonization and Improves Insulin Sensitivity in TRAMP Mice: Evidence for Cancer Cell-Extrinsic CAMKK2 Functions in Prostate Cancer

Cells / Jun 10, 2022

Pulliam, T. L., Awad, D., Han, J. J., Murray, M. M., Ackroyd, J. J., Goli, P., Oakhill, J. S., Scott, J. W., Ittmann, M. M., & Frigo, D. E. (2022). Systemic Ablation of Camkk2 Impairs Metastatic Colonization and Improves Insulin Sensitivity in TRAMP Mice: Evidence for Cancer Cell-Extrinsic CAMKK2 Functions in Prostate Cancer. Cells, 11(12), 1890. https://doi.org/10.3390/cells11121890

Regulation and role of CAMKK2 in prostate cancer

Nature Reviews Urology / Apr 26, 2022

Pulliam, T. L., Goli, P., Awad, D., Lin, C., Wilkenfeld, S. R., & Frigo, D. E. (2022). Regulation and role of CAMKK2 in prostate cancer. Nature Reviews Urology, 19(6), 367–380. https://doi.org/10.1038/s41585-022-00588-z

Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes

Journal of Medicinal Chemistry / Jul 15, 2021

Eduful, B. J., O’Byrne, S. N., Temme, L., Asquith, C. R. M., Liang, Y., Picado, A., Pilotte, J. R., Hossain, M. A., Wells, C. I., Zuercher, W. J., Catta-Preta, C. M. C., Zonzini Ramos, P., Santiago, A. de S., Couñago, R. M., Langendorf, C. G., Nay, K., Oakhill, J. S., Pulliam, T. L., Lin, C., … Drewry, D. H. (2021). Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes. Journal of Medicinal Chemistry, 64(15), 10849–10877. https://doi.org/10.1021/acs.jmedchem.0c02274

Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signaling

Oncogene / Feb 02, 2021

Lin, C., Blessing, A. M., Pulliam, T. L., Shi, Y., Wilkenfeld, S. R., Han, J. J., Murray, M. M., Pham, A. H., Duong, K., Brun, S. N., Shaw, R. J., Ittmann, M. M., & Frigo, D. E. (2021). Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signaling. Oncogene, 40(9), 1690–1705. https://doi.org/10.1038/s41388-021-01658-z

Prostate Cancer Energetics and Biosynthesis

Advances in Experimental Medicine and Biology / Jan 01, 2019

Lin, C., Salzillo, T. C., Bader, D. A., Wilkenfeld, S. R., Awad, D., Pulliam, T. L., Dutta, P., Pudakalakatti, S., Titus, M., McGuire, S. E., Bhattacharya, P. K., & Frigo, D. E. (2019). Prostate Cancer Energetics and Biosynthesis. In Prostate Cancer (pp. 185–237). Springer International Publishing. https://doi.org/10.1007/978-3-030-32656-2_10

Delineation of the androgen-regulated signaling pathways in prostate cancer facilitates the development of novel therapeutic approaches

Current Opinion in Pharmacology / Aug 01, 2018

Awad, D., Pulliam, T. L., Lin, C., Wilkenfeld, S. R., & Frigo, D. E. (2018). Delineation of the androgen-regulated signaling pathways in prostate cancer facilitates the development of novel therapeutic approaches. Current Opinion in Pharmacology, 41, 1–11. https://doi.org/10.1016/j.coph.2018.03.002

GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling

Endocrine-Related Cancer / Apr 01, 2018

White, M. A., Tsouko, E., Lin, C., Rajapakshe, K., Spencer, J. M., Wilkenfeld, S. R., Vakili, S. S., Pulliam, T. L., Awad, D., Nikolos, F., Katreddy, R. R., Kaipparettu, B. A., Sreekumar, A., Zhang, X., Cheung, E., Coarfa, C., & Frigo, D. E. (2018). GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling. Endocrine-Related Cancer, 25(4), 453–469. https://doi.org/10.1530/erc-17-0051

Education

The University of Texas MD Anderson Cancer Center

Post-doctoral Fellow, Cancer Systems Imaging

Houston

University of Houston

PhD, Cell and Molecular Biology / May, 2021

Houston

Lamar University

BSc, Biology / December, 2014

Beaumont

University of Maryland Global Campus Asia

None, None / September, 2010

Yokota Air Force Base

Experience

The University of Texas MD Anderson Cancer Center

Post-doctoral Fellow / August, 2021 — Present

University of Houston

Graduate Research Assitant / October, 2017 — May, 2021

Graduate Teaching Assitant / August, 2016 — October, 2017

Texas General Land Office

Beach Water Sample Analzyer / May, 2014 — December, 2014

United States Marine Corps

Chemical, Biological, Nuclear, Radiological Defense Specialist / August, 2008 — August, 2012

Join Thomas on NotedSource!
Join Now

At NotedSource, we believe that professors, post-docs, scientists and other researchers have deep, untapped knowledge and expertise that can be leveraged to drive innovation within companies. NotedSource is committed to bridging the gap between academia and industry by providing a platform for collaboration with industry and networking with other researchers.

For industry, NotedSource identifies the right academic experts in 24 hours to help organizations build and grow. With a platform of thousands of knowledgeable PhDs, scientists, and industry experts, NotedSource makes connecting and collaborating easy.

For academic researchers such as professors, post-docs, and Ph.D.s, NotedSource provides tools to discover and connect to your colleagues with messaging and news feeds, in addition to the opportunity to be paid for your collaboration with vetted partners.

Expert Institutions
NotedSource has experts from Stanford University
Expert institutions using NotedSource include Oxfort University
Experts from McGill have used NotedSource to share their expertise
University of Chicago experts have used NotedSource
MIT researchers have used NotedSource
Proudly trusted by
Microsoft uses NotedSource for academic partnerships
Johnson & Johnson academic research projects on NotedSource
ProQuest (Clarivate) uses NotedSource as their industry academia platform
Slamom consulting engages academics for research collaboration on NotedSource
Omnicom and OMG find academics on notedsource
Unilever research project have used NotedSource to engage academic experts

Connect with researchers and scientists like Thomas Pulliam on NotedSource to help your company with innovation, research, R&D, L&D, and more.